MPPNTSKVYS YFECREKKTE NSKLRKVKYE ETVFYGLQYI LNKYLKGKVV TKEKIQEAKD VYKEHFQDDV FNEKGWNYIL EKYDGHLPIE IKAVPEGFVI PRGNVLFTVE NTDPECYWLT NWIETILVQS WYPITVATNS REQKKILAKY LLETSGNLDG LEYKLHDFGY RGVSSQETAG IGASAHLVNF KGTDTVAGLA LIKKYYGTKD PVPGYSVPAA EHSTITAWGK DHEKDAFEHI VTQFSSVPVS VVSDSYDIYN ACEKIWGEDL RHLIVSRSTQ APLIIRPDSG NPLDTVLKVL EILGKKFPVT ENSKGYKLLP PYLRVIQGDG VDINTLQEIV EGMKQKMWSI ENIAFGSGGG LLQKLTRDLL NCSFKCSYVV TNGLGINVFK DPVADPNKRS KKGRLSLHRT PAGNFVTLEE GKGDLEEYGQ DLLHTVFKNG KVTKSYSFDE IRKNAQLNIE LEAAHH

MW prédit

52.6 kDa

Biologiquement actif

Yes

Activité biologique

The activity is determined by its ability to induce IL-6, IL-1 beta and TNF alpha production from human PBMCs at 100 ng/ml.

Pureté

>90% as determined by SDS-PAGE.

Forme du produit

Lyophilized

Concentration

Reconstitution dependent.

Formulation

Lyophilized without additives.

Stockage

Shipped at ambient temperature. Lyophilized: Short term (3 weeks) store at 25°C. Long term store desiccated below -18°C. Reconstituted: Short term (2-7 days) store at 4°C. Long term store below -18°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.

Synonymes

1110035O14Rik, AI314458, AI480535, DKFZP666B131, EC 2.4.2.12, MGC117256, NAmPRTase, Nampt, NAMPT_HUMAN, Nicotinamide phosphoribosyltransferase, PBEF, PBEF 1, PBEF1, Pre B cell colony enhancing factor, Pre B cell colony enhancing factor 1, Pre B cell enhancing factor, Pre-B cell-enhancing factor, Pre-B-cell colony-enhancing factor 1, VF

Avertissement

Ce produit est uniquement destiné à la recherche. Il n'est pas destiné à un usage diagnostique ou thérapeutique.